Daily peritoneal administration of sodium pyrophosphate in a dialysis solution prevents the development of vascular calcification in a mouse model of uraemia.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Volumn 26, Issue 10, 2011, Pages 3349-3357

  Riser, Bruce L ^a   Barreto, Fellype Carvalho ^b   Rezg, Raja ^b   Valaitis, Paul W ^b   Cook, Chyung S ^b   White, Jeffrey A ^b   Gass, Jerome H ^b   Maizel, Julien ^b   Louvet, Loic ^b   Drueke, Tilman B ^b   Holmes, Clifford J ^b   Massy, Ziad A ^b  

^a BAXTER HEALTHCARE CORPORATION   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CALCIUM; DIALYSIS FLUID; PYROPHOSPHATE;

ANIMAL; ARTICLE; BLOOD VESSEL CALCIFICATION; FEMALE; HALF LIFE TIME; KIDNEY FAILURE; MALE; METABOLISM; MOUSE; MOUSE MUTANT; PERITONEAL DIALYSIS; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION; UREMIA;

ANIMALS; APOLIPOPROTEINS E; CALCIUM; DIALYSIS SOLUTIONS; DIPHOSPHATES; FEMALE; HALF-LIFE; MALE; MICE; MICE, KNOCKOUT; PERITONEAL DIALYSIS; RATS; RATS, SPRAGUE-DAWLEY; RENAL INSUFFICIENCY; TISSUE DISTRIBUTION; UREMIA; VASCULAR CALCIFICATION;

EID: 79960322874     PISSN: None     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr039     Document Type: Article

References (0)